filmov
tv
Utilizing AI for Early Alzheimer's interventions | Cognetivity
Показать описание
Sina Habibi, Co-founder & CEO of Cognetivity Neurosciences (CSE: CGN) discusses the advancement in Alzheimer’s drugs, treatments and screening processes. He also shares some of Cognetivity's recent collaborations and agreements as well as some of the exciting things to watch for with Cognetivity in the near term.
00:00 Introduction
00:33 Potential of Leqembi, the new Alzheimer's drug
01:54 How close we are to Alzheimer's cure stage
02:33 Increase in Alzheimer's disease market
03:32 Why Alzheimer's is becoming prevalent
04:03 What is Cognetivity Neurosciences?
06:47 Difference of CognICA from other Technologies
08:21 Role of AI in medicine and treatment plans
09:22 Cognetivity to assist in delivery of new Alzheimer's Drugs
11:39 Capabilities of CognICA
12:45 Collaboration with Alzheimer's Society in Oman
14:21 Agreement with Mitsui Sumitomo Aioi Life Insurance
15:51 Plans in collaborating with other organizations
17:00 What investors should look out for
Cognetivity is a tech firm that has developed a cognitive testing platform for use in medical, commercial, and consumer environments. Through the use of AI and machine learning, the tech is able to detect the early onset of Alzheimer’s and dementia through testing the performance of large areas of the brain. The tech has acquired regulatory approval for use in both the UK and Europe, with further approvals in North America anticipated to occur.
#alzheimer #ai #medicine #treatment #cognitivescience #technology
===========
Looking for better insights on the markets? The Deep Dive Spotlights is providing exclusive industry insights from executives, insiders, technicians, specialists and more.
We're upgrading our Canadian small cap coverage from written to visual, hitting investors with a double dose of market insights to provide a special look into just what's happening in the Canadian public markets.
Catch our full suite of content below:
Disclaimer:
Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security. The Deep Dive and its affiliates hold no licenses.
00:00 Introduction
00:33 Potential of Leqembi, the new Alzheimer's drug
01:54 How close we are to Alzheimer's cure stage
02:33 Increase in Alzheimer's disease market
03:32 Why Alzheimer's is becoming prevalent
04:03 What is Cognetivity Neurosciences?
06:47 Difference of CognICA from other Technologies
08:21 Role of AI in medicine and treatment plans
09:22 Cognetivity to assist in delivery of new Alzheimer's Drugs
11:39 Capabilities of CognICA
12:45 Collaboration with Alzheimer's Society in Oman
14:21 Agreement with Mitsui Sumitomo Aioi Life Insurance
15:51 Plans in collaborating with other organizations
17:00 What investors should look out for
Cognetivity is a tech firm that has developed a cognitive testing platform for use in medical, commercial, and consumer environments. Through the use of AI and machine learning, the tech is able to detect the early onset of Alzheimer’s and dementia through testing the performance of large areas of the brain. The tech has acquired regulatory approval for use in both the UK and Europe, with further approvals in North America anticipated to occur.
#alzheimer #ai #medicine #treatment #cognitivescience #technology
===========
Looking for better insights on the markets? The Deep Dive Spotlights is providing exclusive industry insights from executives, insiders, technicians, specialists and more.
We're upgrading our Canadian small cap coverage from written to visual, hitting investors with a double dose of market insights to provide a special look into just what's happening in the Canadian public markets.
Catch our full suite of content below:
Disclaimer:
Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security. The Deep Dive and its affiliates hold no licenses.
0:02:33
How AI can help detect the early signs of Alzheimer's
0:01:19
AI ML For Early Detection of Alzheimer's - Breakthrough Research #artificialintelligence #alzhe...
0:03:15
AI that predicts progress of Alzheimer's disease
0:01:50
Artificial Intelligence Tool Developed for Alzheimer’s Research
0:01:16
Artificial intelligence helping doctors at Emory diagnose Alzheimer's, other forms of dementia
0:05:23
How AI can help detect early warning signs of Alzheimer’s disease
0:05:18
The hope for early detection of Alzheimer's disease
0:02:34
Machine learning in Alzheimer’s disease
0:02:13
Cambridge researchers use AI for early detection of Alzheimer's disease | World tech DNA | WION
0:01:04
Using AI to detect Alzheimer's disease dementia
0:02:56
AI detects Alzheimer’s
0:02:20
What's New in AI? Helping Predict Alzheimer's
0:13:29
AI in Personalized Alzheimer's Disease Detection
0:08:02
Alzheimer's Disease: Using Artificial Intelligence to Detect Changes on PET Scan
0:07:02
Using Artificial Intelligence To Detect Alzheimer's Disease
0:01:57
Alzheimer’s spotted early using AI cookie theft test
0:59:05
Artificial Intelligence and Alzheimer’s: How AI Is Revolutionizing Dementia Detection and Treatment...
0:01:00
AI and Alzheimer's Disease Diagnosis: A Game Changer for Healthcare
0:02:18
Korean scientists develop commercial kit for early diagnosis of Alzheimer's Disease, using ...
0:05:33
Is artificial intelligence smart enough now to predict Alzheimer's?
0:01:46
EARLY DETECTION OF ALZHEIMER’S DISEASE USING COGNITIVE FEATURES A VOTING−BASED ENSEMBLE MACHINE LEAR...
0:04:35
MSU working to detect early signs of Alzheimer’s disease
0:01:34
Artificial Intelligence detects Alzheimer's disease early
0:00:32
How long until ChatGPT cures Alzheimer’s? 🤖🩺
Комментарии